Indianapolis, INDIANA2 Active Studies

Chronic Spontaneous Urticaria Clinical Trials in Indianapolis, INDIANA

Find 2 actively recruiting chronic spontaneous urticaria clinical trials in Indianapolis, INDIANA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
155
Enrolling

Recruiting Chronic Spontaneous Urticaria Studies in Indianapolis

About Chronic Spontaneous Urticaria Clinical Trials in Indianapolis

Chronic spontaneous urticaria involves the recurrence of hives and/or angioedema for more than six weeks without an identifiable external trigger. It significantly impacts quality of life. Treatment includes second-generation antihistamines and biologics like omalizumab.

There are currently 2 chronic spontaneous urticaria clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 155 participants. Research is being sponsored by Jasper Therapeutics, Inc., InflaRx GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Spontaneous Urticaria Clinical Trials in Indianapolis — FAQ

Are there chronic spontaneous urticaria clinical trials in Indianapolis?

Yes, there are 2 chronic spontaneous urticaria clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What chronic spontaneous urticaria treatments are being tested?

The 2 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for chronic spontaneous urticaria.

Data updated March 2, 2026 from ClinicalTrials.gov